Khosla S et al. |
Correlates of osteoprotegerin levels in women and men. |
2002 |
Osteoporos Int |
pmid:12086350
|
Price PA et al. |
Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. |
2002 |
J. Bone Miner. Res. |
pmid:12096831
|
Xing L et al. |
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. |
2002 |
J. Bone Miner. Res. |
pmid:12096833
|
Zou W and Bar-Shavit Z |
Dual modulation of osteoclast differentiation by lipopolysaccharide. |
2002 |
J. Bone Miner. Res. |
pmid:12096834
|
Koyama H et al. |
Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. |
2002 |
J. Bone Miner. Res. |
pmid:12096835
|
Langdahl BL et al. |
Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. |
2002 |
J. Bone Miner. Res. |
pmid:12096838
|
Zhang J et al. |
Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. |
2002 |
J. Bone Miner. Res. |
pmid:12096839
|
Saidenberg Kermanac'h N et al. |
Osteoprotegerin and inflammation. |
2002 Apr-Jun |
Eur. Cytokine Netw. |
pmid:12101070
|
Katagiri T and Takahashi N |
Regulatory mechanisms of osteoblast and osteoclast differentiation. |
2002 |
Oral Dis |
pmid:12108759
|
Lee SK and Lorenzo JA |
Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. |
2002 |
Bone |
pmid:12110442
|
Shioi A et al. |
Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. |
2002 |
Circ. Res. |
pmid:12114316
|
Lipton A et al. |
Serum osteoprotegerin levels in healthy controls and cancer patients. |
2002 |
Clin. Cancer Res. |
pmid:12114435
|
Biskobing DM et al. |
Novel therapeutic options for osteoporosis. |
2002 |
Curr Opin Rheumatol |
pmid:12118183
|
Whyte MP et al. |
Osteoprotegerin deficiency and juvenile Paget's disease. |
2002 |
N. Engl. J. Med. |
pmid:12124406
|
Krane SM |
Genetic control of bone remodeling--insights from a rare disease. |
2002 |
N. Engl. J. Med. |
pmid:12124412
|
Ziolkowska M et al. |
High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. |
2002 |
Arthritis Rheum. |
pmid:12124857
|
Campagnuolo G et al. |
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. |
2002 |
Arthritis Rheum. |
pmid:12124878
|
Sakata M et al. |
Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. |
2002 |
Cytokine |
pmid:12126649
|
Petersson M et al. |
Oxytocin stimulates proliferation of human osteoblast-like cells. |
2002 |
Peptides |
pmid:12126740
|
Grisar J et al. |
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. |
2002 |
J. Rheumatol. |
pmid:12136902
|